RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Rezolute, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 24, 2026
$3.70+0.12 (+3.35%)
Close on Oct 19, 2026
- Market cap
- $386.60M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.99 (−57.42%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $386.60M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.84
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$77.59M
- EPS, diluted
- -$0.75
- Book value per share
- $0.96
- Diluted shares
- 104M
Fifteen years at a glance
Fiscal years 2010 to 2026, USD
Operating income
-$82.97M
Net income
-$77.59M
EPS, diluted
-$0.75
Free cash flow
–
Reported period